Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00048763
Status:
COMPLETED
Last Update Posted:
2005-07-19
First Post:
2002-11-07
Brief Title:
Safety and Efficacy of PletalCilostazol for the Treatment of Juvenile Primary and Secondary Raynauds Phenomenon
Sponsor:
Otsuka America Pharmaceutical
Organization:
Otsuka America Pharmaceutical